26 April 2023

TruSpine Technologies plc

("TruSpine" or the "Company")

Shareholder Requisition Notice

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has received an email dated 14 April 2023 from Janice Stone, Peter Houghton, Todd Michael Cramer and Christopher Blank (together the "Named Shareholders"), who hold in excess of 5 per cent. of the issued share capital of the Company, requiring that the Company convene, as soon as reasonably practicable, a general meeting ("Requisition").

The board changes proposed by the Named Shareholders are:

i.      that Norman Lott be removed as a director and company secretary of the Company;

ii.     that Nikunj Patel be removed as a director of the Company;

iii.    that Annabel Schild be removed as a director of the Company;

iv.   that Laurence Strauss be removed as a director of the Company;

v.    that Todd Michael Cramer be appointed as a director of the Company;

vi.   that Peter Houghton be appointed as a director of the Company;

vii.  that Anthony Swoboda be appointed a director of the Company; and

viii. that the adjourned 2022 annual general meeting be re-convened as soon as reasonably practical.

The letter is a requisition by the Named Shareholders under section 303 of the Companies Act 2006.

The Company is mindful that, pursuant to section 304 of the Companies Act 2006, the Company must post a notice convening a general meeting within 21 days from the date on which the requisition was received, and this meeting must be held on a date not more than 28 days after the date of the notice to shareholders convening the general meeting.

A further announcement will be made regarding a general meeting in due course.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.